Archives

  • 2026-11
  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • D-Luciferin Sodium Salt: Gold Standard Firefly Luciferase...

    2026-03-24

    D-Luciferin Sodium Salt: Gold Standard Firefly Luciferase Substrate for Non-Invasive Bioluminescence Imaging

    Executive Summary: D-Luciferin sodium salt is a highly soluble, ATP-dependent bioluminescent substrate optimized for firefly luciferase reporter assays, enabling non-invasive, quantitative imaging of cell viability, metabolism, and gene expression (APExBIO product page). Its mechanism involves enzymatic oxidation in the presence of oxygen, yielding visible light proportional to ATP levels (Gu et al., 2025). Used extensively in oncology and cell biology, this reagent supports robust, reproducible monitoring of cellular energy dynamics. Stable in DMSO and water, but not ethanol, D-Luciferin sodium salt (SKU B8311) is supplied by APExBIO for sensitive, high-throughput applications. Recent advances in immuno-oncology, such as CAR macrophage programming, leverage this substrate for real-time, in vivo functional readouts (fezolinetantchem.com).

    Biological Rationale

    D-Luciferin sodium salt (CAS 103404-75-7) is the canonical substrate for firefly luciferase enzymes, mediating ATP-dependent bioluminescence. This reaction is pivotal for non-invasive assays of cellular viability, metabolic activity, and gene expression in living cells and animal models (APExBIO). The emitted light intensity directly correlates with intracellular ATP concentration, enabling sensitive detection of energy metabolism (Gu et al., 2025). This property is critical in translational oncology, where monitoring tumor burden, cell proliferation, or response to therapy requires precise, real-time measurement tools. D-Luciferin sodium salt is thus foundational for bioluminescence imaging (BLI) platforms in both academic and pharmaceutical research (biotin-16-ctp.com).

    Mechanism of Action of D-Luciferin sodium salt

    D-Luciferin sodium salt serves as the substrate for firefly luciferase, an ATP-dependent monooxygenase. In the presence of ATP, Mg2+, and molecular oxygen, luciferase catalyzes the oxidation of D-luciferin to oxyluciferin, CO2, AMP, and light (peak emission: 560 nm) (Gu et al., 2025). This enzymatic oxidation is highly specific and stoichiometric, making the system ideal for quantifying intracellular ATP and, by extension, cell viability. D-Luciferin sodium salt is highly soluble in DMSO (≥30.2 mg/mL) and water (≥24.6 mg/mL), but insoluble in ethanol, ensuring compatibility with a wide range of assay buffers (APExBIO). The product is stable at -20°C as a solid; solutions should be prepared fresh and used promptly to maintain maximal activity. The light output is proportional to the amount of ATP and luciferase present, providing quantitative data for metabolic or reporter gene activity (renilla-luciferase.com).

    Evidence & Benchmarks

    • D-Luciferin sodium salt enables in vivo imaging of CAR macrophage activity, correlating light emission with cell viability and gene expression in mouse models (Gu et al., 2025, https://doi.org/10.1038/s41467-025-67674-9).
    • Solubility benchmarks: ≥30.2 mg/mL in DMSO, ≥24.6 mg/mL in water at 20°C; insoluble in ethanol (APExBIO product info, product page).
    • BLI using D-Luciferin sodium salt detects as few as 1000 luciferase-positive cells in vivo, with linearity over 4–5 orders of magnitude (fezolinetantchem.com, internal article).
    • ATP-dependent bioluminescence assays achieve high signal-to-background ratios (>100:1) in luciferase-expressing cell lines (biotin-16-ctp.com, internal article).
    • Stability: Dry powder is stable for ≥12 months at -20°C in sealed containers; aqueous solutions degrade within days at room temperature (APExBIO, product page).

    Applications, Limits & Misconceptions

    D-Luciferin sodium salt is widely used for non-invasive metabolic imaging, cell viability and cytotoxicity assays, gene expression quantification, and in vivo tracking of cell or tumor progression. It is a primary reagent in oncology research for monitoring response to immunotherapies, including CAR macrophage and CAR T-cell approaches (Gu et al., 2025). Recent translational studies leverage this substrate to visualize immune cell dynamics and tumor-immune interactions in real time (fezolinetantchem.com). This article extends the mechanistic insights from biotin-16-ctp.com by providing benchmark solubility and stability data under defined conditions.

    Common Pitfalls or Misconceptions

    • Not a universal cell viability marker: The assay only detects luciferase-expressing cells; non-transduced populations yield no signal.
    • ATP-dependence: The reaction strictly requires cellular ATP; compromised or necrotic cells may underreport viability.
    • Solution stability: Aqueous D-Luciferin sodium salt solutions degrade rapidly; do not store for extended periods.
    • Ethanol incompatibility: Insoluble in ethanol; use only DMSO or water-based buffers for dissolution.
    • Oxygen dependence: Hypoxic environments may yield artificially low signals due to reduced luciferase activity.

    Workflow Integration & Parameters

    D-Luciferin sodium salt (SKU B8311) from APExBIO integrates readily into standard luciferase reporter workflows. Reconstitute in DMSO or water per solubility benchmarks. For in vitro assays, add substrate to culture media at typical final concentrations of 150–300 μg/mL, incubate 5–15 minutes, and measure luminescence using a luminometer or BLI platform. For in vivo imaging, inject D-Luciferin sodium salt (e.g., 150 mg/kg, i.p.) in animal models expressing firefly luciferase, and image within 10–20 minutes post-administration (Gu et al., 2025). Always use freshly prepared solutions and store dry powder at –20°C. For robust ATP-dependent bioluminescence assays, ensure proper buffer pH (7.2–7.8), and adequate oxygenation. For troubleshooting and advanced workflow scenarios, see this guide, which this article updates by providing precise solubility and stability parameters.

    Conclusion & Outlook

    D-Luciferin sodium salt remains the gold standard for non-invasive metabolic imaging and luciferase reporter assays. Its high solubility, ATP-dependence, and robust signal-to-background ratio support sensitive, quantitative research in oncology, immunology, and cell metabolism. Careful attention to reagent preparation, storage, and assay design is essential for reproducible results. APExBIO’s high-purity B8311 formulation ensures reliability across platforms. As emerging immuno-oncology techniques—such as mRNA-LNP programming of CAR macrophages—expand, D-Luciferin sodium salt will continue to underpin translational workflows, enabling real-time functional analysis of cellular energy metabolism and immune response (Gu et al., 2025). For more on mechanistic and translational aspects, see this resource, which this article supplements by highlighting updated in vivo benchmarks and assay parameters.